Cellia Science Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2M
- Investors
-
2
Cellia Science General Information
Description
Developer of commercialized blood cell analyzer technology designed to provide rapid, actionable blood cell counts in any setting from the clinic to the home. The company offers point-of-care hematology through the development of devices by utilize the inherent UV absorbance of nucleic acids and proteins within cells and are capable of identifying full white blood cell differentials, enabling labs to test with just a drop of blood from a finger prick or venous sample.
Contact Information
Website
www.celliasci.comCorporate Office
- 535 West Research Center Boulevard
- Suite 135
- Fayetteville, AR 72701
- United States
Corporate Office
- 535 West Research Center Boulevard
- Suite 135
- Fayetteville, AR 72701
- United States
Cellia Science Timeline
Cellia Science Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 13-Jun-2025 | $2M | Completed | Startup | ||
| 4. Grant | 09-Oct-2023 | Completed | Startup | |||
| 3. Early Stage VC | 26-May-2023 | Completed | Startup | |||
| 2. Grant | 15-Feb-2023 | $1.8M | $250K | Completed | Startup | |
| 1. Early Stage VC | 15-Nov-2022 | $250K | $250K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cellia Science Patents
Cellia Science Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025188609-A1 | Methods and systems for assessment of biological specimen adequacy | Pending | 05-Mar-2024 | ||
| WO-2025188609-A8 | Methods and systems for assessment of biological specimen adequacy | Pending | 05-Mar-2024 | ||
| US-20240189820-A1 | Cell imaging and compression system and methods of use thereof | Pending | 08-Dec-2022 | B01L3/50273 |
Cellia Science Signals
Cellia Science Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| VIC Technology Venture Development | Venture Capital | Minority |
Cellia Science FAQs
-
When was Cellia Science founded?
Cellia Science was founded in 2021.
-
Where is Cellia Science headquartered?
Cellia Science is headquartered in Fayetteville, AR.
-
What is the size of Cellia Science?
Cellia Science has 3 total employees.
-
What industry is Cellia Science in?
Cellia Science’s primary industry is Diagnostic Equipment.
-
Is Cellia Science a private or public company?
Cellia Science is a Private company.
-
What is Cellia Science’s current revenue?
The current revenue for Cellia Science is .
-
How much funding has Cellia Science raised over time?
Cellia Science has raised $300K.
-
Who are Cellia Science’s investors?
National Institutes of Health and VIC Technology Venture Development have invested in Cellia Science.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process